Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyCarmine Zoccali, Rainer H. Böger, Stefanie M. Bode‐Böger et al.|The Lancet|2001Cited by 1.1k
An introduction to inverse probability of treatment weighting in observational researchNicholas C Chesnaye, Kitty J. Jager, Vianda S Stel et al.|Clinical Kidney Journal|2021Cited by 877
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal DiseaseCarmine Zoccali, Yūji Matsuzawa, Giuseppe Seminara et al.|Journal of the American Society of Nephrology|2002Cited by 761
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal DiseaseCarmine Zoccali, Lorenzo Malatino, Francesca Mallamaci et al.|Circulation|2002Cited by 522
Sample size calculations: basic principles and common pitfallsM. Noordzij, Kitty J. Jager, Giovanni Tripepi et al.|Nephrology Dialysis Transplantation|2010Cited by 447